Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chaihu-jia-Longgu-Muli-tang (CLM) is a classical Traditional Chinese Medicine (TCM) herbal formula originally described in the 'Shang Han Lun'. It is a multi-herb decoction composed of eleven ingredients, including Radix Bupleuri, Fossilia Ossia Mastodi, and Ostreae Testa. CLM is primarily investigated for the treatment of depressive disorders, including post-stroke depression. Its mechanism of action is thought to involve the upregulation of hippocampal brain-derived neurotrophic factor (BDNF) and modulation of the hypothalamic-pituitary-adrenal (HPA) axis. Key active constituents identified include saponins such as saikosaponin a. It is currently being evaluated in clinical trials sponsored by institutions like the Nanjing University of Chinese Medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chaihu jia longgu muli tang.